| Title |
Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer
|
|---|---|
| Published in |
Cancer Chemotherapy and Pharmacology, April 2010
|
| DOI | 10.1007/s00280-010-1299-8 |
| Pubmed ID | |
| Authors |
Emmanuel Mitry, Pascal Hammel, Gaël Deplanque, Françoise Mornex, Philippe Levy, Jean-François Seitz, Alain Moussy, Jean-Pierre Kinet, Olivier Hermine, Philippe Rougier, Eric Raymond |
Mendeley readers
The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 3% |
| Unknown | 37 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Doctoral Student | 7 | 18% |
| Researcher | 6 | 16% |
| Student > Ph. D. Student | 6 | 16% |
| Student > Bachelor | 4 | 11% |
| Student > Master | 4 | 11% |
| Other | 6 | 16% |
| Unknown | 5 | 13% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 12 | 32% |
| Agricultural and Biological Sciences | 7 | 18% |
| Biochemistry, Genetics and Molecular Biology | 2 | 5% |
| Nursing and Health Professions | 1 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 3% |
| Other | 4 | 11% |
| Unknown | 11 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 55. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 June 2019.
All research outputs
#694,944
of 23,815,455 outputs
Outputs from Cancer Chemotherapy and Pharmacology
#14
of 2,501 outputs
Outputs of similar age
#1,935
of 97,569 outputs
Outputs of similar age from Cancer Chemotherapy and Pharmacology
#1
of 24 outputs
Altmetric has tracked 23,815,455 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,501 research outputs from this source. They receive a mean Attention Score of 4.1. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 97,569 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.